ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPK Opko Health Inc

1.27
0.05 (4.10%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Opko Health Inc OPK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 4.10% 1.27 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.25 1.22 1.28 1.27 1.22
more quote information »

Recent News

Date Time Source Heading
28/3/202423:00PRNUSLabcorp Announces Acquisition of Select Assets of..
20/3/202423:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
08/3/202408:02EDGAR2Form ARS - Annual Report to Security Holders
06/3/202400:52GLOBEAIDS Clinical Trial Group Presents Results from Phase 1..
02/3/202408:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
29/2/202401:31PRNUSNextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
28/2/202408:07EDGAR2Form 8-K - Current report
28/2/202408:05GLOBEOPKO Health Reports Fourth Quarter 2023 Business Highlights..
23/2/202408:05GLOBEOPKO Health to Report Fourth Quarter 2023 Financial Results..
17/2/202408:53EDGAR2Form PRE 14A - Other preliminary proxy statements
10/2/202408:07EDGAR2Form 8-K - Current report
06/2/202400:09PRNUSNextPlat Receives Initial Approvals to Launch OPKO..
30/1/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202408:15EDGAR2Form SC 13D/A - General statement of acquisition of..
25/1/202408:00EDGAR2Form 8-K - Current report
18/1/202409:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202409:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202409:09EDGAR2Form 8-K - Current report
10/1/202408:05GLOBEOPKO Health Announces Closing of Private Offering of $230..
09/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:00GLOBEOPKO Health to Present at the 42nd Annual J.P. Morgan..
06/1/202409:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202405:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202404:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202423:00EDGAR2Form 8-K - Current report
05/1/202415:31GLOBEOPKO Health Announces Pricing of Private Offering of $200..
04/1/202409:05GLOBEOPKO Health Announces Private Offering of Convertible Senior..
28/11/202323:00PRNUSBioReference Health and Prognos Health Collaborate to..
14/11/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:45PRNUSBioReference® Signs On as the First Laboratory to Use..
07/11/202308:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202308:06EDGAR2Form 8-K - Current report
07/11/202308:05GLOBEOPKO Health Reports Third Quarter 2023 Business Highlights..
03/11/202301:00GLOBENew Clinical Data on OPKO Health’s RAYALDEE® (ER..
01/11/202307:08EDGAR2Form 8-K/A - Current report: [Amend]
31/10/202323:00GLOBEOPKO Health to Report Third Quarter 2023 Financial Results..
26/10/202307:25GLOBEOPKO Health to Present New Clinical Data on Rayaldee (ER..
29/9/202307:10DJNModeX Therapeutics Awarded Contract to Address Public Health..
29/9/202306:09EDGAR2Form 8-K - Current report
29/9/202306:08GLOBEModeX Therapeutics Secures BARDA Contract to Develop Novel..
12/9/202322:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
04/8/202306:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:07EDGAR2Form 8-K - Current report
04/8/202306:05GLOBEOPKO Health Reports Second Quarter 2023 Business Highlights..
26/7/202306:05GLOBEOPKO Health to Report Second Quarter 2023 Financial Results..
01/7/202306:10EDGAR2Form 8-K - Current report
28/6/202320:45BWFDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly..
04/5/202306:05GLOBEOPKO Health Reports First Quarter 2023 Business Highlights..

Your Recent History

Delayed Upgrade Clock